August 1, 2016

CDC recommends bacterial meningitis vaccine may be given to provide short term protection to anyone 16 to 23 years of age.

August 1, 2016

Through this partnership, CVS Pharmacy patients purchasing Narcan Nasal Spray without insurance will receive a $35 discount coupon to purchase the medication.

August 1, 2016

Qbrelis is the first and only FDA-approved oral solution to treat hypertension in adults and pediatric patients 6 years of age and older, the company said.

August 1, 2016

The drug can now be used to treat lower limb spasticity in pediatric patients ages 2 years and older. 

August 1, 2016
With the acquisition, Pfizer gains Bamboo’s gene therapy expertise, as well as an advanced recombinant Adeno-associated virus (rAAV) vector design and production technology and a gene therapy manufacturing facility for Phase I/II materials. 
July 29, 2016

Comfort Vision has added a 90-Pack configuration for ProOcular daily disposable contact lenses.

July 26, 2016

To address recommendations by the Advisory Committee on Immunization Practices, Sanofi Pasteur has increased production of Fluzone Quadrivalent vaccine where possible.

July 22, 2016

Teva announced that its Octreotide Acetate Injection, 50 mcg/mL, is back in stock and ready to order. 

July 20, 2016

The pilot program would allow the Department of Defense to access lower pricing for prescriptions dispensed at community pharmacies.

July 20, 2016

"Working together with NCPA staff, the Innovation Center will help better position independent community pharmacies to be part of and benefit from broader health care changes," suggested Doug Hoey, NCPA CEO.

July 19, 2016

The drug is a new formulation of lorcaserin that can offer patients once-daily dosing and could help maintain weight loss. 

July 19, 2016
The new indication makes the drug available for treatment-naïve adults with type 2 diabetes as an adjunct to diet and exercise as a way of improving glycemic control. 
July 19, 2016
The expanded label also comes with two new dosage strengths, which the companies said will be available in September. 
July 18, 2016

Cefaly I has a tremendous success record. In clinical trials 81% of compliant patients showed a significant reduction in migraine attacks and up to a 75% reduction in consumption of migraine medications.

July 18, 2016

The Food and Drug Administration has approved a bew indication for Janssen Therapeutics’ Prezista (darunavir), the company announced Monday.

July 18, 2016

Industry organizations have responded to the Food and Drug Administration’s issuing of a document with details on the reauthorization of the Prescription Drug User Fee agreement. 

July 13, 2016
Reuters is reporting that the FDA’s Arthritis Advisory Board has unanimously recommended Amgen’s biosimilar of AbbVie’s Humira, ABP 501. The panel said that the drug was similar in safety and effectiveness to Humira for rheumatoid arthritis and plaque psoriasis, and it recommended that the biosimilar should also be approved for Crohn’s disease in adults and ulcerative colitis. (Reuters)
July 12, 2016

Xiidra marks Shire's first approval for a drug in the ophthalmic space, which it hopes to enter using Xiidra as leverage for its pipeline of developing ophthalmic. 

July 12, 2016

FDA approval of the 2016/17 formulation of Flublok means that Flublok is on track to ship to healthcare providers in early August.   

July 11, 2016

The Pushtronex system is an on-body infusor with a pre-filled cartridge with a 420-mg monthly dose of the cholesterol-lowering drug, one of two new drugs in a class of PCSK9 inhibitors. 

July 11, 2016

Vollmer, who has been Iroko’s president since March 2015 has been in the pharmaceutical industry for more than 25 years, including his role as one of three founders of Endo Pharmaceuticals.

July 7, 2016
Canada's health minister has signed an order allowing access to Narcan (naloxone) nasal spray as the government conducts an expedited review of the product. 
July 1, 2016
Humira was first approved in 2003, and has since been approved in more than 90 countries. 
June 30, 2016
Epclusa, which treats all genotypes of hepatitis C, received Priority Review and Breakthrough Therapy designations from the FDA.